Doc. Mgr. Jiří Vrba, Ph.D.

Jiří Vrba (Assoc. Prof., PhD, MSc.)

Department of Medical Chemistry and Biochemistry

Hněvotínská 3

775 15 Olomouc, Czech Republic

e-mail: j.vrba@upol.cz

tel: +420 585 63 2310

 

Research Topics:

  • Molecular toxicology and pharmacology; Biological activity of low molecular weight compounds
  • Natural and synthetic compounds; Biological interactions; Biotransformation

 

Position:

2017               

Associate Professor, Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Olomouc

 

Education and employment:

From 2017

Associate Professor, Palacky University, Olomouc

2012 – 2017

Assistant Professor, Palacky University, Olomouc

2004 – 2011

Research Assistant, Palacky University, Olomouc

2001 – 2005

PhD study, Palacky University, Olomouc

1996 – 2001

Analyst, Tekro Ltd, Prague

1990 – 1995

MSc study, Palacky University, Olomouc

 

Membership:

2002 – present

Czech Chemical Society

2004 – present                       

Czech Society for Biochemistry and Molecular Biology

 

Teaching activites:

2001 – present

Biochemistry (Faculty of Medicine and Dentistry, Palacky University, Olomouc)

2003 – present

Medical chemistry (Faculty of Medicine and Dentistry, Palacky University, Olomouc)

 

Research Fellowships:

2005

Sanofi Aventis, Vitry sur Seine, France

2009

University of Texas M. D. Anderson Cancer Center, Houston, USA

 

Publications:

  • 38 original papers
  • 2 reviews
  • 1 textbook

 

  • Recent publications:

Vrba J., Papoušková B., Lněničková K., Kosina P., Křen V., Ulrichová J. Identification of UDP-glucuronosyltransferases involved in the metabolism of silymarin flavonolignans. Journal of Pharmaceutical and Biomedical Analysis 178, art. no. 112972 (2020).
Novák D., Vrba J., Zatloukalová M., Roubalová L., Stolarczyk K., Dorčák V., Vacek J. Cysteamine assay for the evaluation of bioactive electrophiles. Free Radical Biology and Medicine 164, 381-389 (2021).
Vrba J., Papoušková B., Lněničková K., Kosina P., Křen V., Ulrichová J. Metabolism of 2,3-Dehydrosilybin A and 2,3-Dehydrosilybin B: A Study with Human Hepatocytes and Recombinant UDP-Glucuronosyltransferases and Sulfotransferases. Antioxidants (Basel) 10(6):954 (2021).
Weber P., Mészáros Z., Jagečić D., Hribljan V., Mitrečić D., Bojarová P., Slámová K., Vrba J., Kulik N., Křen V., Stütz AE. Diaminocyclopentane-derived O-GlcNAcase inhibitors for combating tau hyperphosphorylation in Alzheimer’s disease. Chemical Communications (Camb) 58(63):8838-8841 (2022).